Summary

Asia-Pacific Prosthetic Heart Valve Market
The Asia-Pacific prosthetic heart valve market was valued at $2.0 billion in 2023 and is projected to reach $6.2 billion by 2033, growing at a CAGR of 11.9% from 2024 to 2033.
A prosthetic heart valve is an artificial implant that replaces the damaged native valve of the human heart for its efficient functioning. It is either mechanical, formed from plastic or metal, or bioprosthetic, which is created using animal or human tissues. Similar to the natural heart valves, a prosthetic heart valve opens & closes during every heartbeat and enables sufficient flow of blood into the body. A major advantage of the prosthetic heart valve is its durability as it functions ideally for 20-30 years after implantation. This reduces the possibility of blood clotting around the valve surface and eliminates the requirement for lifelong blood thinning therapies.

Asia-Pacific harbors the highest geriatric population across the globe. This fuels the demand for prosthetic heart valves and propels the growth of the market. In addition, upsurge in expenditure on healthcare by consumers acts as a key driver of the Asia-Pacific prosthetic heart valve market. Furthermore, surge in the implementation of supportive government strategies across different nations to expand their health service industry is expected to augment the market development. To enhance the efficacy and biomimicry of prosthetic heart valves, the use of latest techniques of 3D printing is trending in the market. Manufacturers are utilizing biomaterial inks and ingenious techniques such as bioplotting & melt electrowriting to print living cells.

However, high costs of the valves and implantation surgeries deters several patients with budget sensitivities from undergoing the procedure. This limits the demand for prosthetic heart valves and hampers the market development. Moreover, staffing problems in the region due to the lack of skilled healthcare providers and surgeons have an overall restraining impact on the Asia-Pacific prosthetic heart valve market. On the contrary, rise in prevalence of cardiovascular diseases (CVD) in the region is poised to present lucrative opportunities for the market growth. According to the Asia-Pacific Cardiovascular Disease Alliance, a multisectoral coalition, CVD is the leading cause of death in Asia-Pacific, accounting for approximately 35% of the overall mortality. Furthermore, the region alone contributes to around 58% of the global CVD deaths every year. These figures are poised to rise in the future, thereby fueling the demand for efficient cardiovascular healthcare and opening new avenues for the Asia-Pacific prosthetic heart valve market.

Segment Review
The Asia-Pacific prosthetic heart valve market is segmented into product and region. On the basis of product, the market is divided into tissue heart valve, mechanical heart valve, and transcatheter heart valve. Country wise, it is analyzed across Japan, China, India, Australia, South Korea, and Rest of Asia-Pacific.
Key Findings
On the basis of product, the transcatheter heart valve segment held a high share of the market in 2023.
Competition Analysis
The leading players operating in the Asia-Pacific prosthetic heart valve market include Edwards Lifesciences Corporation, TTK, SMT, Relisys Medical Devices Limited, Medtronic, Heart Care India Co., Boston Scientific Corporation, Meril Life Sciences Pvt. Ltd., P+F Products + Features GmbH, and Peijia Medical Limited. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:
● Quarterly Update and* (only available with a corporate license, on listed price)
● 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
● Free Upcoming Version on the Purchase of Five and Enterprise User License.
● 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
● 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
● Free data Pack on the Five and Enterprise User License. (Excel version of the report)
● Free Updated report if the report is 6-12 months old or older.
● 24-hour priority response*
● Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
● Regulatory Guidelines
● Additional company profiles with specific to client's interest
● Additional country or region analysis- market size and forecast
● Expanded list for Company Profiles
● Historic market data
Key Market Segments
By Product
● Tissue Heart Valve
○ Stented Tissue Heart Valve
○ Stentless Tissue Heart Valve
● Mechanical Heart Valve
● Transcatheter Heart Valve
By Country
● Japan
● China
● India
● Australia
● South Korea
● Rest Of Asia-Pacific
● Key Market Players
○ Edwards Lifesciences Corporation
○ TTK
○ SMT
○ Relisys Medical Devices Limited
○ Medtronic
○ Heart Care India Co
○ Boston Scientific Corporation
○ Meril Life Sciences Pvt. Ltd.
○ P+F Products + Features GmbH
○ Peijia Medical Limited

ページTOPに戻る

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET, BY PRODUCT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. Tissue Heart Valve
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Share Analysis, By Country
4.2.3. Stented Tissue Heart Valve
4.2.4. Stentless Tissue Heart Valve
4.3. Mechanical Heart Valve
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Share Analysis, By Country
4.4. Transcatheter Heart Valve
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Share Analysis, By Country
CHAPTER 5: ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET, BY COUNTRY
5.1. Market Overview
5.1.1 Market Size and Forecast, By Country
5.2. Asia-Pacific
5.2.2. Key Market Trends and Opportunities
5.2.2. Market Size and Forecast, By Product
5.2.3. Market Size and Forecast, By Country
5.2.4.Japan
5.2.4.1. Market Size and Forecast, By Product
5.2.5.China
5.2.5.1. Market Size and Forecast, By Product
5.2.6.India
5.2.6.1. Market Size and Forecast, By Product
5.2.7.Australia
5.2.7.1. Market Size and Forecast, By Product
5.2.8.South Korea
5.2.8.1. Market Size and Forecast, By Product
5.2.9.Rest of Asia Pacific
5.2.9.1. Market Size and Forecast, By Product
CHAPTER 6: COMPETITIVE LANDSCAPE
6.1. Introduction
6.2. Top Winning Strategies
6.3. Product Mapping Of Top 10 Player
6.4. Competitive Dashboard
6.5. Competitive Heatmap
6.6. Top Player Positioning,2023
CHAPTER 7: COMPANY PROFILES
7.1. Edwards Lifesciences Corporation
7.1.1. Company Overview
7.1.2. Key Executives
7.1.3. Company Snapshot
7.1.4. Operating Business Segments
7.1.5. Product Portfolio
7.1.6. Business Performance
7.1.7. Key Strategic Moves and Developments
7.2. TTK
7.2.1. Company Overview
7.2.2. Key Executives
7.2.3. Company Snapshot
7.2.4. Operating Business Segments
7.2.5. Product Portfolio
7.2.6. Business Performance
7.2.7. Key Strategic Moves and Developments
7.3. SMT
7.3.1. Company Overview
7.3.2. Key Executives
7.3.3. Company Snapshot
7.3.4. Operating Business Segments
7.3.5. Product Portfolio
7.3.6. Business Performance
7.3.7. Key Strategic Moves and Developments
7.4. Relisys Medical Devices Limited
7.4.1. Company Overview
7.4.2. Key Executives
7.4.3. Company Snapshot
7.4.4. Operating Business Segments
7.4.5. Product Portfolio
7.4.6. Business Performance
7.4.7. Key Strategic Moves and Developments
7.5. Medtronic
7.5.1. Company Overview
7.5.2. Key Executives
7.5.3. Company Snapshot
7.5.4. Operating Business Segments
7.5.5. Product Portfolio
7.5.6. Business Performance
7.5.7. Key Strategic Moves and Developments
7.6. Heart Care India Co
7.6.1. Company Overview
7.6.2. Key Executives
7.6.3. Company Snapshot
7.6.4. Operating Business Segments
7.6.5. Product Portfolio
7.6.6. Business Performance
7.6.7. Key Strategic Moves and Developments
7.7. Boston Scientific Corporation
7.7.1. Company Overview
7.7.2. Key Executives
7.7.3. Company Snapshot
7.7.4. Operating Business Segments
7.7.5. Product Portfolio
7.7.6. Business Performance
7.7.7. Key Strategic Moves and Developments
7.8. Meril Life Sciences Pvt. Ltd.
7.8.1. Company Overview
7.8.2. Key Executives
7.8.3. Company Snapshot
7.8.4. Operating Business Segments
7.8.5. Product Portfolio
7.8.6. Business Performance
7.8.7. Key Strategic Moves and Developments
7.9. P+F Products + Features GmbH
7.9.1. Company Overview
7.9.2. Key Executives
7.9.3. Company Snapshot
7.9.4. Operating Business Segments
7.9.5. Product Portfolio
7.9.6. Business Performance
7.9.7. Key Strategic Moves and Developments
7.10. Peijia Medical Limited
7.10.1. Company Overview
7.10.2. Key Executives
7.10.3. Company Snapshot
7.10.4. Operating Business Segments
7.10.5. Product Portfolio
7.10.6. Business Performance
7.10.7. Key Strategic Moves and Developments
LIST OF TABLES
TABLE 1. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 2. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET FOR TISSUE HEART VALVE, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 3. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET FOR MECHANICAL HEART VALVE, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 4. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET FOR TRANSCATHETER HEART VALVE, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 5. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 6. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 7. JAPAN PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 8. CHINA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 9. INDIA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 10. AUSTRALIA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 11. SOUTH KOREA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 12. REST OF ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
TABLE 13. EDWARDS LIFESCIENCES CORPORATION: KEY EXECUTIVES
TABLE 14. EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
TABLE 15. EDWARDS LIFESCIENCES CORPORATION: OPERATING SEGMENTS
TABLE 16. EDWARDS LIFESCIENCES CORPORATION: PRODUCT PORTFOLIO
TABLE 17. EDWARDS LIFESCIENCES CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 18. TTK: KEY EXECUTIVES
TABLE 19. TTK: COMPANY SNAPSHOT
TABLE 20. TTK: OPERATING SEGMENTS
TABLE 21. TTK: PRODUCT PORTFOLIO
TABLE 22. TTK: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 23. SMT: KEY EXECUTIVES
TABLE 24. SMT: COMPANY SNAPSHOT
TABLE 25. SMT: OPERATING SEGMENTS
TABLE 26. SMT: PRODUCT PORTFOLIO
TABLE 27. SMT: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 28. RELISYS MEDICAL DEVICES LIMITED: KEY EXECUTIVES
TABLE 29. RELISYS MEDICAL DEVICES LIMITED: COMPANY SNAPSHOT
TABLE 30. RELISYS MEDICAL DEVICES LIMITED: OPERATING SEGMENTS
TABLE 31. RELISYS MEDICAL DEVICES LIMITED: PRODUCT PORTFOLIO
TABLE 32. RELISYS MEDICAL DEVICES LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 33. MEDTRONIC: KEY EXECUTIVES
TABLE 34. MEDTRONIC: COMPANY SNAPSHOT
TABLE 35. MEDTRONIC: OPERATING SEGMENTS
TABLE 36. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 37. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 38. HEART CARE INDIA CO: KEY EXECUTIVES
TABLE 39. HEART CARE INDIA CO: COMPANY SNAPSHOT
TABLE 40. HEART CARE INDIA CO: OPERATING SEGMENTS
TABLE 41. HEART CARE INDIA CO: PRODUCT PORTFOLIO
TABLE 42. HEART CARE INDIA CO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 43. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
TABLE 44. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 45. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 46. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 47. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 48. MERIL LIFE SCIENCES PVT. LTD.: KEY EXECUTIVES
TABLE 49. MERIL LIFE SCIENCES PVT. LTD.: COMPANY SNAPSHOT
TABLE 50. MERIL LIFE SCIENCES PVT. LTD.: OPERATING SEGMENTS
TABLE 51. MERIL LIFE SCIENCES PVT. LTD.: PRODUCT PORTFOLIO
TABLE 52. MERIL LIFE SCIENCES PVT. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 53. P+F PRODUCTS + FEATURES GMBH: KEY EXECUTIVES
TABLE 54. P+F PRODUCTS + FEATURES GMBH: COMPANY SNAPSHOT
TABLE 55. P+F PRODUCTS + FEATURES GMBH: OPERATING SEGMENTS
TABLE 56. P+F PRODUCTS + FEATURES GMBH: PRODUCT PORTFOLIO
TABLE 57. P+F PRODUCTS + FEATURES GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 58. PEIJIA MEDICAL LIMITED: KEY EXECUTIVES
TABLE 59. PEIJIA MEDICAL LIMITED: COMPANY SNAPSHOT
TABLE 60. PEIJIA MEDICAL LIMITED: OPERATING SEGMENTS
TABLE 61. PEIJIA MEDICAL LIMITED: PRODUCT PORTFOLIO
TABLE 62. PEIJIA MEDICAL LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 1. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET,2024 - 2033
FIGURE 2. SEGMENTATION OF ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET,2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET,2024 - 2033
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET
FIGURE 10. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET , BY PRODUCT,2024 - 2033 ($BILLION)
FIGURE 11. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET FOR TISSUE HEART VALVE, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 12. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET FOR MECHANICAL HEART VALVE, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET FOR TRANSCATHETER HEART VALVE, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 14. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 15. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 16. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 17. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 18. COMPETITIVE DASHBOARD
FIGURE 19. COMPETITIVE HEATMAP: ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET
FIGURE 20. TOP PLAYER POSITIONING,2023
FIGURE 21. EDWARDS LIFESCIENCES CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 22. EDWARDS LIFESCIENCES CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 23. EDWARDS LIFESCIENCES CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 24. TTK: NET SALES, 2021-2023 ($BILLION)
FIGURE 25. TTK: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 26. TTK: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 27. SMT: NET SALES, 2021-2023 ($BILLION)
FIGURE 28. SMT: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 29. SMT: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 30. RELISYS MEDICAL DEVICES LIMITED: NET SALES, 2021-2023 ($BILLION)
FIGURE 31. RELISYS MEDICAL DEVICES LIMITED: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 32. RELISYS MEDICAL DEVICES LIMITED: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 33. MEDTRONIC: NET SALES, 2021-2023 ($BILLION)
FIGURE 34. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 35. MEDTRONIC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 36. HEART CARE INDIA CO: NET SALES, 2021-2023 ($BILLION)
FIGURE 37. HEART CARE INDIA CO: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 38. HEART CARE INDIA CO: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 39. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 40. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 41. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 42. MERIL LIFE SCIENCES PVT. LTD.: NET SALES, 2021-2023 ($BILLION)
FIGURE 43. MERIL LIFE SCIENCES PVT. LTD.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 44. MERIL LIFE SCIENCES PVT. LTD.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 45. P+F PRODUCTS + FEATURES GMBH: NET SALES, 2021-2023 ($BILLION)
FIGURE 46. P+F PRODUCTS + FEATURES GMBH: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 47. P+F PRODUCTS + FEATURES GMBH: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 48. PEIJIA MEDICAL LIMITED: NET SALES, 2021-2023 ($BILLION)
FIGURE 49. PEIJIA MEDICAL LIMITED: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 50. PEIJIA MEDICAL LIMITED: REVENUE SHARE, BY REGION, 2023 (%)